Hras helps hippo heterodimerize to evade tumor suppression

References

• Hancock JF. Ras proteins: different signals from different locations. Nat Rev Mol Cell Biol 2003; 4:373-84; PMID:12728271; https://doi.org/10.1038/nrm1105
   PubMed Web of Science ®Google Scholar
• Pylayeva-Gupta Y, Grabocka E, Bar-Sagi D. RAS oncogenes: weaving a tumorigenic web. Nat Rev Cancer 2011; 11:761-74; PMID:21993244; https://doi.org/10.1038/nrc3106
   PubMed Web of Science ®Google Scholar
• Castellano E, Santos E. Functional specificity of ras isoforms: so similar but so different. Genes Cancer 2011; 2:216-31; PMID:21779495; https://doi.org/10.1177/1947601911408081
   PubMedGoogle Scholar
• Yan J, Roy S, Apolloni A, Lane A, Hancock JF. Ras isoforms vary in their ability to activate Raf-1 and phosphoinositide 3-kinase. J Biol Chem 1998; 273:24052-6; PMID:9727023; https://doi.org/10.1074/jbc.273.37.24052
   PubMed Web of Science ®Google Scholar
• Zhao B, Li L, Lei Q, Guan KL. The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version. Genes Dev 2010; 24:862-74; PMID:20439427; https://doi.org/10.1101/gad.1909210
   PubMed Web of Science ®Google Scholar
• Zeng Q, Hong W. The emerging role of the hippo pathway in cell contact inhibition, organ size control, and cancer development in mammals. Cancer Cell 2008; 13:188-92; PMID:18328423; https://doi.org/10.1016/j.ccr.2008.02.011
   PubMed Web of Science ®Google Scholar
• Zhou D, Medoff BD, Chen L, Li L, Zhang XF, Praskova M, Liu M, Landry A, Blumberg RS, Boussiotis VA, et al. The Nore1B/Mst1 complex restrains antigen receptor-induced proliferation of naive T cells. Proc Natl Acad Sci U S A 2008; 105:20321-6; PMID:19073936; https://doi.org/10.1073/pnas.0810773105
   PubMed Web of Science ®Google Scholar
• Song H, Mak KK, Topol L, Yun K, Hu J, Garrett L, Chen Y, Park O, Chang J, Simpson RM, et al. Mammalian Mst1 and Mst2 kinases play essential roles in organ size control and tumor suppression. Proc Natl Acad Sci U S A 2010; 107:1431-6; PMID:20080598; https://doi.org/10.1073/pnas.0911409107
   PubMed Web of Science ®Google Scholar
• Rawat SJ, Chernoff J. Regulation of mammalian Ste20 (Mst) kinases. Trends Biochem Sci 2015; 40:149-56; PMID:25665457; https://doi.org/10.1016/j.tibs.2015.01.001
   PubMed Web of Science ®Google Scholar
• Matallanas D, Romano D, Al-Mulla F, O'Neill E, Al-Ali W, Crespo P, Doyle B, Nixon C, Sansom O, Drosten M, et al. Mutant K-Ras activation of the proapoptotic MST2 pathway is antagonized by wild-type K-Ras. Mol Cell 2011; 44:893-906; PMID:22195963; https://doi.org/10.1016/j.molcel.2011.10.016
   PubMed Web of Science ®Google Scholar
• Del Re DP, Matsuda T, Zhai P, Maejima Y, Jain MR, Liu T, Li H, Hsu CP, Sadoshima J. Mst1 promotes cardiac myocyte apoptosis through phosphorylation and inhibition of Bcl-xL. Mol Cell 2014; 54:639-50; PMID:24813943; https://doi.org/10.1016/j.molcel.2014.04.007
   PubMed Web of Science ®Google Scholar
• Rawat SJ, Araiza-Olivera D, Arias-Romero LE, Villamar-Cruz O, Prudnikova TY, Roder H, Chernoff J. H-ras Inhibits the Hippo Pathway by Promoting Mst1/Mst2 Heterodimerization. Curr Biol 2016; 26:1556-63; PMID:27238285; https://doi.org/10.1016/j.cub.2016.04.027
   PubMed Web of Science ®Google Scholar
• Creasy CL, Chernoff J. Cloning and characterization of a human protein kinase with homology to Ste20. J Biol Chem 1995; 270:21695-700; PMID:7665586; https://doi.org/10.1074/jbc.270.37.21695
   PubMed Web of Science ®Google Scholar
• Hwang E, Cheong HK, Ul Mushtaq A, Kim HY, Yeo KJ, Kim E, Lee WC, Hwang KY, Cheong C, Jeon YH. Structural basis of the heterodimerization of the MST and RASSF SARAH domains in the Hippo signalling pathway. Acta Crystallogr D Biol Crystallogr 2014; 70:1944-53; PMID:25004971; https://doi.org/10.1107/S139900471400947X
   PubMed Web of Science ®Google Scholar
• Hwang E, Ryu KS, Paakkonen K, Guntert P, Cheong HK, Lim DS, Lee JO, Jeon YH, Cheong C. Structural insight into dimeric interaction of the SARAH domains from Mst1 and RASSF family proteins in the apoptosis pathway. Proc Natl Acad Sci U S A 2007; 104:9236-41; PMID:17517604; https://doi.org/10.1073/pnas.0610716104
   PubMed Web of Science ®Google Scholar
• Ni L, Li S, Yu J, Min J, Brautigam CA, Tomchick DR, Pan D, Luo X. Structural Basis for Autoactivation of Human Mst2 Kinase and Its Regulation by RASSF5. Structure 2013; 21:1757-68; PMID:23972470; https://doi.org/10.1016/j.str.2013.07.008
   PubMed Web of Science ®Google Scholar
• Sanchez-Sanz G, Matallanas D, Nguyen LK, Kholodenko BN, Rosta E, Kolch W, Buchete NV. MST2-RASSF protein-protein interactions through SARAH domains. Brief Bioinform 2016; 17:593-602; PMID:26443615; https://doi.org/10.1093/bib/bbv070
   PubMed Web of Science ®Google Scholar
• O'Neill E, Rushworth L, Baccarini M, Kolch W. Role of the kinase MST2 in suppression of apoptosis by the proto-oncogene product Raf-1. Science 2004; 306:2267-70; PMID:15618521; https://doi.org/10.1126/science.1103233
   PubMed Web of Science ®Google Scholar
• Romano D, Matallanas D, Weitsman G, Preisinger C, Ng T, Kolch W. Proapoptotic kinase MST2 coordinates signaling crosstalk between RASSF1A, Raf-1, and Akt. Cancer Res 2010; 70:1195-203; PMID:20086174; https://doi.org/10.1158/0008-5472.CAN-09-3147
   PubMed Web of Science ®Google Scholar
• Rawat SJ, Creasy CL, Peterson JR, Chernoff J. The tumor suppressor Mst1 promotes changes in the cellular redox state by phosphorylation and inactivation of peroxiredoxin-1 protein. J Biol Chem 2013; 288:8762-71; PMID:23386615; https://doi.org/10.1074/jbc.M112.414524
   PubMed Web of Science ®Google Scholar
• Sudol M, Harvey KF. Modularity in the Hippo signaling pathway. Trends Biochem Sci 2010; 35:627-33; PMID:20598891; https://doi.org/10.1016/j.tibs.2010.05.010
   PubMed Web of Science ®Google Scholar
• Sciarretta S, Zhai P, Maejima Y, Del Re DP, Nagarajan N, Yee D, Liu T, Magnuson MA, Volpe M, Frati G, et al. mTORC2 regulates cardiac response to stress by inhibiting MST1. Cell Rep 2015; 11:125-36; PMID:25843706; https://doi.org/10.1016/j.celrep.2015.03.010
   PubMed Web of Science ®Google Scholar
• Romano D, Maccario H, Doherty C, Quinn NP, Kolch W, Matallanas D. The differential effects of wild-type and mutated K-Ras on MST2 signaling are determined by K-Ras activation kinetics. Mol Cell Biol 2013; 33:1859-68; PMID:23459937; https://doi.org/10.1128/MCB.01414-12
   PubMed Web of Science ®Google Scholar
• Salojin KV, Hamman BD, Chang WC, Jhaver KG, Al-Shami A, Crisostomo J, Wilkins C, Digeorge-Foushee AM, Allen J, Patel N, et al. Genetic deletion of Mst1 alters T cell function and protects against autoimmunity. PloS one 2014; 9:e98151; PMID:24852423; https://doi.org/10.1371/journal.pone.0098151
   PubMed Web of Science ®Google Scholar
• Du X, Shi H, Li J, Dong Y, Liang J, Ye J, Kong S, Zhang S, Zhong T, Yuan Z, et al. Mst1/Mst2 regulate development and function of regulatory T cells through modulation of Foxo1/Foxo3 stability in autoimmune disease. J Immunol 2014; 192:1525-35; PMID:24453252; https://doi.org/10.4049/jimmunol.1301060
   PubMed Web of Science ®Google Scholar
• Dang TS, Willet JD, Griffin HR, Morgan NV, O'Boyle G, Arkwright PD, Hughes SM, Abinun M, Tee LJ, Barge D, et al. Defective Leukocyte Adhesion and Chemotaxis Contributes to Combined Immunodeficiency in Humans with Autosomal Recessive MST1 Deficiency. J Clin Immunol 2016; 36:117-22; PMID:26801501; https://doi.org/10.1007/s10875-016-0232-2
   PubMed Web of Science ®Google Scholar